Ezeibe, M.C.O. and Ogbonna, I.J. (2016) Use of the Medicinal Synthetic Aluminum Magnesium Silicate to Enhance Efficacy of Antimicrobials, for Prevention and Treatment of Resistant Infections. 2nd International Conference and Exhibition on Pharmacology and Ethnopharmacology, Chicago, 2-4 May 2016.

has been cited by the following article:

• TITLE: HIV-Infection Reduction-Rates in Patients, on Antiretroviral Efficacy-Trial of a Nigerian Broad-Spectrum Antiviral Medicine (Antivirt®)

  AUTHORS: M. C. O. Ezeibe, B. L. Salako, F. I. O. Onyeachonam, A. David, O. O. Aina, E. Herbertson, M. E. Sanda, I. J. Ogbonna, E. Kalu, N. U. Njoku, M. I. Udobi, C. A. Akpan

  KEYWORDS: Antivirt®, Opposite Charges’ Electrostatic Attraction, Continuous Depletion Of HIV-Infection Loads

  JOURNAL NAME: World Journal of AIDS, Vol.10 No.2, June 30, 2020

  ABSTRACT: In verifying antiretroviral efficacy of a Nigerian broad spectrum antiviral medicine (Antivirt®), the Nigerian Institute of Medical Research certified it safe by toxicological test on laboratory animals, before commencing treatment of three HIV/AIDS patients whose viral loads varied widely (millions, hundreds of thousands and thousands). To overcome errors associated with such wide differences in subject-classes, percentages of viral load-reductions were calculated instead of comparing their viral loads. After first month of the Antivirt®-treatment, means of ranked viral loads of the patients significantly (P ≤ 0.05) increased from 10.00 ± 7.21 to 11.30 ± 5.51 (-41.03% infection-reduction rate) instead of reducing. From second month of the trial, their viral loads started to reduce, continuously, so that their infection-reduction rates have been increasing from that -41.03%, to -38.22% in the second month; 23.98% in the third month; 31.76% in the fourth month and 64.12% after the fifth month.